{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:01:30Z","timestamp":1792404090675,"version":"4.4.0"},"reference-count":248,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"crossref","award":["HI14C3331"],"award-info":[{"award-number":["HI14C3331"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["FRD2016-19"],"award-info":[{"award-number":["FRD2016-19"]}]},{"DOI":"10.13039\/501100002631","name":"Gachon University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jns.2017.03.031","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T07:36:06Z","timestamp":1490168166000},"page":"242-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":244,"special_numbering":"C","title":["Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis"],"prefix":"10.1016","volume":"376","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0487-8668","authenticated-orcid":false,"given":"Eva","family":"Bagyinszky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vo Van","family":"Giau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyuhwan","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoungho","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Soo A.","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SangYun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2017.03.031_bb0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.wad.0000191420.61260.a8","article-title":"The role of biomarkers in clinical trials for Alzheimer disease","volume":"20","author":"Thal","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.jns.2017.03.031_bb0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0197-4580(03)00002-2","article-title":"Biological markers for therapeutic trials in Alzheimer's disease: proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease","volume":"24","author":"Frank","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.03.031_bb0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-2094-8-26","article-title":"Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease","author":"Grammas","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2017.03.031_bb0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1042\/CS20100094","article-title":"The vascular contribution to Alzheimer's disease","volume":"119","author":"Altman","year":"2010","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.jns.2017.03.031_bb0025","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0031-6997(24)01470-4","article-title":"The sympathetic nerve\u2014an integrative interface between two supersystems: the brain and the immnune system","volume":"52","author":"Elenkov","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jns.2017.03.031_bb0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2009.06.024","article-title":"A neurotransmitter system that regulates macrophage pro-inflammatory functions","volume":"216","author":"Reyes-Garc\u00eda","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0361-9230(01)00428-2","article-title":"Cytokines and the central nervous system","volume":"54","author":"Szel\u00e9nyi","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jns.2017.03.031_bb0040","doi-asserted-by":"crossref","DOI":"10.2174\/1567205014666170203141717","article-title":"Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation","author":"Regen","year":"2017","journal-title":"Curr Alzheimer Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0045","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10522-010-9281-8","article-title":"Peripheral inflammatory biomarkers of Alzheimer's disease: the role of platelets","volume":"11","author":"Casoli","year":"2011","journal-title":"Biogerontology"},{"key":"10.1016\/j.jns.2017.03.031_bb0050","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1017\/S1462399411001918","article-title":"Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases","volume":"13","author":"Grammas","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.jns.2017.03.031_bb0055","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/JAD-2009-1158","article-title":"Neuropathology and the neuroinflammation idea","volume":"18","author":"Mrak","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2017.03.031_bb0060","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/archgenpsychiatry.2009.146","article-title":"Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease","volume":"66","author":"van Exel","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jns.2017.03.031_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000237873","article-title":"Inflammation and anti-inflammatory strategies for Alzheimer's disease\u2013a mini-review","volume":"56","author":"McNaull","year":"2010","journal-title":"Gerontology"},{"key":"10.1016\/j.jns.2017.03.031_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-8-34","article-title":"The CCAAT\/enhancer binding protein (C\/EBP) \u03b4 is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-\u03b2 peptide","volume":"8","author":"Ramberg","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2017.03.031_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1039\/c0fo00103a","article-title":"Anti-inflammatory activity of natural dietary flavonoids","volume":"1","author":"Pan","year":"2010","journal-title":"Food Funct."},{"key":"10.1016\/j.jns.2017.03.031_bb0080","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00702-010-0438-z","article-title":"Neuroinflammatory processes in Alzheimer's disease","volume":"117","author":"Heneka","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jns.2017.03.031_bb0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jns.2005.03.012","article-title":"Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia","volume":"233","author":"Calabrese","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2017.03.031_bb0090","series-title":"Update on Dementia","article-title":"Neuroinflammation and neurodegeneration","author":"Morales","year":"2016"},{"key":"10.1016\/j.jns.2017.03.031_bb0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fncel.2014.00112","article-title":"Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches","volume":"8","author":"Morales","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jns.2017.03.031_bb0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11481-008-9142-2","article-title":"Imaging microglial activation duringneuroinflammation and Alzheimer's disease","volume":"4","author":"Venneti","year":"2009","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.jns.2017.03.031_bb0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2217\/fnl.12.6","article-title":"Clearance of amyloid-\u03b2 peptides by microglia and macrophages: the issue of what, when and where","volume":"7","author":"Lai","year":"2012","journal-title":"Future Neurol."},{"key":"10.1016\/j.jns.2017.03.031_bb0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/00207454.2013.833510","article-title":"Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease","volume":"124","author":"Cai","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jns.2017.03.031_bb0115","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jns.2017.03.031_bb0120","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2174\/092986707780597961","article-title":"Microglial activation and its implications in the brain diseases","volume":"14","author":"Dheen","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jns.2017.03.031_bb0125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/187152710791012071","article-title":"Microglia and inflammation in Alzheimer's disease","volume":"9","author":"Mandrekar-Colucci","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jns.2017.03.031_bb0130","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","article-title":"Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease","volume":"49","author":"Simard","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2017.03.031_bb0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fncel.2013.00034","article-title":"Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair","volume":"7","author":"London","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"8","key":"10.1016\/j.jns.2017.03.031_bb0140","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/glia.20973","article-title":"The role and therapeutic potential of monocytic cells in Alzheimer's disease","volume":"58","author":"Malm","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.jns.2017.03.031_bb0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.exger.2015.03.002","article-title":"Migration of blood cells to \u03b2-amyloid plaques in Alzheimer's disease","volume":"65","author":"Hohsfield","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jns.2017.03.031_bb0150","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2174\/138161210793176572","article-title":"Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease","volume":"16","author":"Agostinho","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jns.2017.03.031_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.arr.2014.07.004","article-title":"When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease","volume":"18","author":"Avila-Mu\u00f1oz","year":"2014","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jns.2017.03.031_bb0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-016-0098-z","article-title":"Accumulation of amyloid-\u03b2 by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons","volume":"11","author":"S\u00f6llvander","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jns.2017.03.031_bb0165","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1016\/j.febslet.2011.08.027","article-title":"Astrocytes contain amyloid-\u03b2 annular protofibrils in Alzheimer's disease brains","volume":"585","author":"Lasagna-Reeves","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jns.2017.03.031_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.exger.2009.10.011","article-title":"Growth factors and cytokines\/chemokines as surrogate biomarkers in cerebrospinal fluid and blood for diagnosing Alzheimer's disease and mild cognitive impairment","volume":"45","author":"Olson","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jns.2017.03.031_bb0175","article-title":"Replicating cytokines in modelling signal exchange between nodes in wireless mesh networks","volume":"vol. I","author":"Mowjoon","year":"2009"},{"key":"10.1016\/j.jns.2017.03.031_bb0180","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1172\/JCI32356","article-title":"A beneficial role for IL-1\u03b2 in Alzheimer disease?","volume":"117","author":"Lemere","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jns.2017.03.031_bb0185","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1111\/j.1939-1676.1991.tb03135.x","article-title":"Interleukins: biological properties and therapeutic potential","volume":"5","author":"Elmslie","year":"1991","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.jns.2017.03.031_bb0190","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.neurobiolaging.2008.01.014","article-title":"Inflammatory markers in AD and MCI patients with different biomarker profiles","volume":"30","author":"Schuitemaker","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.03.031_bb0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S1041610208008107","article-title":"IL-6 release by LPS-stimulated peripheral blood mononuclear cells as a potential biomarker in Alzheimer's disease","volume":"21","author":"Kaplin","year":"2009","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.jns.2017.03.031_bb0200","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neurobiolaging.2003.10.009","article-title":"Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease","volume":"25","author":"Arosio","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.03.031_bb0205","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000321666","article-title":"IL-6-174 G\/C and ApoE gene polymorphisms in Alzheimer's and vascular dementia patients attending the cognitive disorder clinic of the All India Institute of Medical Sciences, New Delhi","volume":"30","author":"Mansoori","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jns.2017.03.031_bb0210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0304-3940(98)00136-0","article-title":"Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease","volume":"244","author":"Angelis","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2017.03.031_bb0215","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00406-004-0558-2","article-title":"Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain","volume":"255","author":"Hampel","year":"2006","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jns.2017.03.031_bb0220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/978-3-642-17214-4_11","article-title":"Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes","volume":"2011","author":"Maedler","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jns.2017.03.031_bb0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13206-014-8301-1","article-title":"Characterization of inflammatory biomarkers and candidates for diagnosis of Alzheimer's disease","volume":"8","author":"Bagyinszky","year":"2014","journal-title":"BioChip J."},{"key":"10.1016\/j.jns.2017.03.031_bb0230","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1172\/JCI31450","article-title":"Sustained hippocampal IL-1\u03b2 overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology","volume":"117","author":"Shaftel","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jns.2017.03.031_bb0235","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1038\/cddis.2013.503","article-title":"Oligomeric amyloid \u03b2 induces IL-1\u03b2 processing via production of ROS: implication in Alzheimer's disease","volume":"4","author":"Parajuli","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jns.2017.03.031_bb0240","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2004.10.006","article-title":"IL-8 enhancement of amyloid-beta (Abeta 1-42)-induced expression and production of pro-inflammatory cytokines and COX-2 in cultured human microglia","volume":"159","author":"Franciosi","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0245","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/eji.200939712","article-title":"Nuclear retention of IL-1 alpha by necrotic cells: a mechanism to dampen sterile inflammation","volume":"39","author":"Luheshi","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0250","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N","article-title":"Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism","volume":"47","author":"Grimaldi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2017.03.031_bb0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000104829","article-title":"Interleukin-1alpha and -1beta promoter polymorphisms in Taiwanese patients with dementia","volume":"24","author":"Wang","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jns.2017.03.031_bb0260","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbi.2010.12.004","article-title":"Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer's disease","volume":"25","author":"Saresella","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jns.2017.03.031_bb0265","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.0812530106","article-title":"IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells","volume":"106","author":"Elyaman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2017.03.031_bb0270","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10875-010-9369-6","article-title":"The IL-17 family cytokines in immunity and disease","volume":"30","author":"Pappu","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0275","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1348-0421.2009.00120.x","article-title":"Hypoxia enhances stimulating effect of amyloid beta peptide (25\u201335) for interleukin 17 and T helper lymphocyte subtype 17 upregulation in cultured peripheral blood mononuclear cells","volume":"53","author":"Yin","year":"2009","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-5-23","article-title":"Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease","volume":"5","author":"Jin","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2017.03.031_bb0285","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.4049\/jimmunol.1000142","article-title":"IL-17 enhancement of the IL-6 signaling cascade in astrocytes","volume":"184","author":"Ma","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0290","doi-asserted-by":"crossref","first-page":"e75786","DOI":"10.1371\/journal.pone.0075786","article-title":"Th17 cell-mediated neuroinflammation is involved in neurodegeneration of a\u03b21\u201342-induced Alzheimer's disease model rats","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2017.03.031_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.2009.0005","article-title":"Association between renal injury and reduced interleukin-15 and interleukin-15 receptor levels in acute kidney injury","volume":"30","author":"Eini","year":"2010","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0300","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/0891988706286226","article-title":"IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia","volume":"19","author":"Rentzos","year":"2006","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"2","key":"10.1016\/j.jns.2017.03.031_bb0305","doi-asserted-by":"crossref","first-page":"e0117282","DOI":"10.1371\/journal.pone.0117282","article-title":"Serum interleukin (IL)-15 as a biomarker of Alzheimer's disease","volume":"10","author":"Bishnoi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2017.03.031_bb0310","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jlb.67.6.757","article-title":"Interleukin-16","volume":"67","author":"Cruikshank","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jns.2017.03.031_bb0315","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/08830189809043007","article-title":"Signaling and functional properties of interleukin-16","volume":"16","author":"Cruikshank","year":"1998","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0320","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1111\/j.1460-9568.2006.04780.x","article-title":"Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia","volume":"23","author":"Di Rosa","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jns.2017.03.031_bb0325","first-page":"12","article-title":"Genetic and blood biomarkers of Alzheimer's disease","volume":"2","author":"Momeni","year":"2010","journal-title":"Open Nucl. Med. J."},{"key":"10.1016\/j.jns.2017.03.031_bb0330","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.179.4.1361","article-title":"Impaired interleukin 12 production in human immunodeficiency virus-infected patients","volume":"179","author":"Chehimi","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2017.03.031_bb0335","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jns.2006.05.063","article-title":"Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia","volume":"249","author":"Rentzos","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2017.03.031_bb0340","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.brainres.2008.11.083","article-title":"Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease","volume":"1253","author":"Yu","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0345","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1742-2094-9-199","article-title":"Pro-inflammatory interleukin-18 increases Alzheimer's disease-associated amyloid-\u03b2 production in human neuron-like cells","volume":"9","author":"Sutinen","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2017.03.031_bb0350","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/meth.1999.0837","article-title":"Interleukin-18","volume":"19","author":"Dinarello","year":"1999","journal-title":"Methods"},{"issue":"5","key":"10.1016\/j.jns.2017.03.031_bb0355","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.biopha.2011.04.013","article-title":"Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-fluorouracil in a mouse mucositis model","volume":"65","author":"Wu","year":"2011","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jns.2017.03.031_bb0360","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-5728(98)00188-X","article-title":"Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid [25\u201335]","volume":"93","author":"Meda","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0365","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000051276","article-title":"Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease","volume":"12","author":"Tarkowski","year":"2001","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jns.2017.03.031_bb0370","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1074\/jbc.M110.169367","article-title":"The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1)","volume":"286","author":"Martinez-Nunez","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2017.03.031_bb0375","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-5728(00)00404-5","article-title":"IL-4, IL-10 and IL-13 modulate A beta(1\u201342)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line","volume":"113","author":"Szczepanik","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0380","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.amjmed.2011.02.040","article-title":"Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome","volume":"124","author":"Cavusoglu","year":"2011","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jns.2017.03.031_bb0385","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/01.CIR.0000065232.57371.25","article-title":"Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes","volume":"107","author":"Heeschen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2017.03.031_bb0390","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1080\/00207450701392068","article-title":"Cytokines in Alzheimer's disease and vascular dementia","volume":"118","author":"Angelopoulos","year":"2008","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.jns.2017.03.031_bb0395","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.exger.2006.09.015","article-title":"Increased production of inflammatory cytokines in mild cognitive impairment","volume":"42","author":"Magaki","year":"2007","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jns.2017.03.031_bb0400","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","article-title":"Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology","volume":"85","author":"Guillot-Sestier","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2017.03.031_bb0405","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1084\/jem.20091419","article-title":"Regulation of learning and memory by meningeal immunity: a key role for IL-4","volume":"207","author":"Derecki","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2017.03.031_bb0410","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/1874609810801030192","article-title":"Interleukin-4-induced oxidative stress via microglial NADPH oxidase contributes to the death of hippocampal neurons in vivo","volume":"1","author":"Park","year":"2008","journal-title":"Curr. Aging Sci."},{"key":"10.1016\/j.jns.2017.03.031_bb0415","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.4049\/jimmunol.181.9.6503","article-title":"IL-4-induced selective clearance of oligomeric beta-amyloid peptide(1\u201342) by rat primary type 2 microglia","volume":"181","author":"Shimizu","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0420","doi-asserted-by":"crossref","first-page":"E1339","DOI":"10.1073\/pnas.1102349108","article-title":"FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders","volume":"108","author":"Kiyota","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2017.03.031_bb0425","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1750-1326-7-36","article-title":"Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition","volume":"7","author":"Chakrabarty","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jns.2017.03.031_bb0430","first-page":"374","article-title":"Interferon activation and innate immunity","volume":"2","author":"Le Page","year":"2000","journal-title":"Rev. Immunogenet."},{"key":"10.1016\/j.jns.2017.03.031_bb0435","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1523\/JNEUROSCI.5595-08.2009","article-title":"Interferon-alpha causes neuronal dysfunction in encephalitis","volume":"29","author":"Sas","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2017.03.031_bb0440","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1046\/j.1471-4159.1997.69030939.x","article-title":"Interferon-beta is a potent promoter of nerve growth factor production by astrocytes","volume":"69","author":"Boutros","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2017.03.031_bb0445","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-11-30","article-title":"A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects","volume":"11","author":"Grimaldi","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2017.03.031_bb0450","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.neurobiolaging.2013.10.089","article-title":"Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer's disease","volume":"35","author":"Taylor","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.03.031_bb0455","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/jir.2013.0085","article-title":"IFN-\u03b3 and TNF-\u03b1 are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients","volume":"34","author":"Belkhelfa","year":"2014","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0460","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.4049\/jimmunol.0903382","article-title":"IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice","volume":"184","author":"Chakrabarty","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0465","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1096\/fj.08-105866","article-title":"IFN-gamma enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer's disease","volume":"22","author":"Baron","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.jns.2017.03.031_bb0470","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2353\/ajpath.2009.090059","article-title":"Interferon-{gamma} differentially affects Alzheimer's disease pathologies and induces neurogenesis in triple transgenic-AD mice","volume":"175","author":"Mastrangelo","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jns.2017.03.031_bb0475","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/11310810-000000000-00000","article-title":"Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence","volume":"23","author":"Tobinick","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jns.2017.03.031_bb0480","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(04)00166-7","article-title":"Tumor necrosis factor: an apoptosis JuNKie?","volume":"116","author":"Varfolomeev","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jns.2017.03.031_bb0485","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/glia.20453","article-title":"TNF-alpha\/IFN-gamma-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP\/PKA and intracellular calcium signaling","volume":"55","author":"Hsiao","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.jns.2017.03.031_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2007.10.001","article-title":"Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease","volume":"39","author":"Rojo","year":"2008","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0495","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.dci.2011.06.002","article-title":"Molecular cloning, characterization and expression analysis of the tumor necrosis factor (TNF) superfamily gene, TNF receptor superfamily gene and lipopolysaccharide-induced TNF-\u03b1 factor (LITAF) gene from Litopenaeus vannamei","volume":"36","author":"Wang","year":"2012","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0500","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0197-4580(01)00291-3","article-title":"The role of TNF and its receptors in Alzheimer's disease","volume":"22","author":"Perry","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.03.031_bb0505","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.brainres.2008.10.019","article-title":"Expression and genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A polymorphism in sporadic Alzheimer's disease in a Southern China population","volume":"1247","author":"Yang","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0510","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.nbd.2013.10.007","article-title":"Microglial derived tumor necrosis factor-\u03b1 drives Alzheimer's disease-related neuronal cell cycle events","volume":"62","author":"Bhaskar","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2017.03.031_bb0515","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1006\/cyto.1996.0125","article-title":"Lymphotoxin-alpha (TNF-beta) during sepsis","volume":"8","author":"Sriskandan","year":"1996","journal-title":"Cytokine"},{"key":"10.1016\/j.jns.2017.03.031_bb0520","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1073\/pnas.92.20.9328","article-title":"Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation","volume":"92","author":"Barger","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2017.03.031_bb0525","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/S0021-9258(19)39421-9","article-title":"Amplified expression of tumor necrosis factor receptor in cells transfected with Epstein-Barr virus shuttle vector cDNA libraries","volume":"265","author":"Heller","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2017.03.031_bb0530","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3233\/JAD-2010-1253","article-title":"Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients","volume":"19","author":"Cheng","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2017.03.031_bb0535","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.neurobiolaging.2008.10.012","article-title":"Soluble TNF receptors are associated with A\u03b2 metabolism and conversion to dementia in subjects with mild cognitive impairment","volume":"31","author":"Buchhave","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.03.031_bb0540","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/1567205011666140317103222","article-title":"Plasma amyloid-\u03b2 oligomers and soluble tumor necrosis factor receptors as potential biomarkers of AD","volume":"11","author":"Zhang","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0545","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nri2356","article-title":"Colony-stimulating factors in inflammation and autoimmunity","volume":"8","author":"Hamilton","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0550","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/brain\/awq081","article-title":"Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation","volume":"133","author":"Hesske","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jns.2017.03.031_bb0555","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.2071","article-title":"Engineering superactive granulocyte macrophage colony-stimulating factor transferrin fusion proteins as orally-delivered candidate agents for treating neurodegenerative disease","author":"Heinzelman","year":"2015","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jns.2017.03.031_bb0560","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1093\/hmg\/ddp331","article-title":"Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1\u201342 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease","volume":"18","author":"Manczak","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2017.03.031_bb0565","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2121-12-5","article-title":"Macrophage colony-stimulating factor and its receptor signaling augment glycated albumin-induced retinal microglialinflammation in vitro","volume":"12","author":"Liu","year":"2011","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.jns.2017.03.031_bb0570","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/156720510791383813","article-title":"Macrophage colony-stimulating factor (M-CSF) in plasma and CSF of patients with mild cognitive impairment and Alzheimer's disease","volume":"7","author":"Laske","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0575","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/brain\/awn331","article-title":"Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease","volume":"132","author":"Boissonneault","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jns.2017.03.031_bb0580","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1177\/147323001003800412","article-title":"Granulocyte colony-stimulating factor attenuates chronic neuroinflammation in the brain of amyloid precursor protein transgenic mice: an Alzheimer's disease mouse model","volume":"38","author":"Jiang","year":"2010","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0585","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pbb.2013.05.015","article-title":"Granulocyte colony stimulating factor (GCSF) improves memory and neurobehavior in an amyloid-\u03b2 induced experimental model of Alzheimer's disease","volume":"110","author":"Prakash","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"8","key":"10.1016\/j.jns.2017.03.031_bb0590","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jnr.23378","article-title":"In vivo administration of granulocyte colony-stimulating factor restores long-term depression in hippocampal slices prepared from transgenic APP\/PS1 mice","volume":"92","author":"Song","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0595","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0197-4580(01)00290-1","article-title":"Chemokines and Alzheimer's disease","volume":"22","author":"Streit","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.03.031_bb0600","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/1533317513518651","article-title":"The potential role of chemokines in Alzheimer's disease pathogenesis","volume":"29","author":"Azizi","year":"2014","journal-title":"Am. J. Alzheimers Dis. Other. Demen."},{"key":"10.1016\/j.jns.2017.03.031_bb0605","first-page":"8342","article-title":"Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors","volume":"7","author":"Liu","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jns.2017.03.031_bb0610","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archneur.63.4.538","article-title":"Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease","volume":"63","author":"Galimberti","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2017.03.031_bb0615","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neurobiolaging.2008.03.009","article-title":"RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role","volume":"31","author":"Tripathy","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.03.031_bb0620","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1742-2094-10-86","article-title":"Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain","volume":"10","author":"Selenica","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2017.03.031_bb0625","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.neurobiolaging.2012.08.009","article-title":"CCL2 affects \u03b2-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease","volume":"34","author":"Kiyota","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.03.031_bb0630","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nm1555","article-title":"Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease","volume":"13","author":"El Khoury","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jns.2017.03.031_bb0635","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jmcb\/mjt028","article-title":"A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease","volume":"5","author":"Naert","year":"2013","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.jns.2017.03.031_bb0640","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00415-009-5138-y","article-title":"CCL8\/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration","volume":"256","author":"Villa","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2017.03.031_bb0645","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0306-4522(98)00295-4","article-title":"Localization of macrophage inflammatory protein: macrophage inflammatory proteins 1\u03b1 and 1\u03b2 expression in rat brain after peripheral administration of lipopolysaccharide and focal cerebral ischemia","volume":"88","author":"Gourmala","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2017.03.031_bb0650","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1176\/appi.neuropsych.11060143","article-title":"Decreased expression of CCL3 in monocytes and CCR5 in lymphocytes from frontotemporal dementia as compared with Alzheimer's disease patients","volume":"24","author":"Torres","year":"2012","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jns.2017.03.031_bb0655","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/glia.22732","article-title":"APOE genotype-dependent modulation of astrocyte chemokine CCL3 production","volume":"63","author":"Cudaback","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.jns.2017.03.031_bb0660","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1084\/jem.167.2.570","article-title":"Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties","volume":"167","author":"Wolpe","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2017.03.031_bb0665","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neurobiolaging.2006.02.013","article-title":"Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease","volume":"28","author":"Man","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.03.031_bb0670","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0002-9440(10)65542-3","article-title":"Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains","volume":"153","author":"Xia","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jns.2017.03.031_bb0675","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0000000000000060","article-title":"Age-related brain expression and regulation of the chemokine CCL4\/MIP-1\u03b2 in APP\/PS1 double-transgenic mice","volume":"73","author":"Zhu","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2017.03.031_bb0680","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/JAD-2010-091714","article-title":"Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production","volume":"21","author":"Pellican\u00f2","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2017.03.031_bb0685","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.4049\/jimmunol.171.12.6838","article-title":"Among CXCR3 chemokines, IFN-gamma-inducible protein of 10kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease","volume":"171","author":"Christen","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0690","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s11064-007-9554-z","article-title":"Decreased fractalkine and increased IP-10 expression in aged brain of APP(swe) transgenic mice","volume":"33","author":"Duan","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0695","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1182\/blood.V89.8.2635","article-title":"Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo","volume":"89","author":"Sgadari","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jns.2017.03.031_bb0700","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-5728(00)00285-X","article-title":"Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1\/2 activation and role in Alzheimer's disease","volume":"108","author":"Xia","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0705","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.imlet.2008.09.004","article-title":"Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment","volume":"121","author":"Lee","year":"2008","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jns.2017.03.031_bb0710","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1172\/JCI66771","article-title":"CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model","volume":"125","author":"Krauthausen","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jns.2017.03.031_bb0715","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/B:HIJO.0000032355.66152.b8","article-title":"CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion","volume":"35","author":"Kucia","year":"2004","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.jns.2017.03.031_bb0720","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JAD-2008-15107","article-title":"Decreased CXCL12 (SDF-1) plasma levels in early Alzheimer's disease: a contribution to a deficient hematopoietic brain support?","volume":"15","author":"Laske","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2017.03.031_bb0725","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2012.04.011","article-title":"Stromal cell-derived factor 1\u03b1 decreases \u03b2-amyloid deposition in Alzheimer's disease mouse model","volume":"1459","author":"Wang","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0730","first-page":"1149","article-title":"Differential induction of GRO alpha gene expression in human corneal epithelial cells and keratocytes exposed to proinflammatory cytokines","volume":"38","author":"Cubitt","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jns.2017.03.031_bb0735","doi-asserted-by":"crossref","first-page":"e18850","DOI":"10.1371\/journal.pone.0018850","article-title":"Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis","volume":"6","author":"Craig-Schapiro","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2017.03.031_bb0740","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000245156","article-title":"Peripheral cytokines and chemokines in Alzheimer's disease","volume":"28","author":"Lee","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jns.2017.03.031_bb0745","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/brain\/awt323","article-title":"Fractalkine activates NRF2\/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis","volume":"137","author":"Lastres-Becker","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jns.2017.03.031_bb0750","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nn.2511","article-title":"Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease","volume":"13","author":"Fuhrmann","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jns.2017.03.031_bb0755","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1100\/2012\/756357","article-title":"A review: inflammatory process in Alzheimer's disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.jns.2017.03.031_bb0760","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/0006-291X(90)91229-L","article-title":"Transforming growth factor-beta bound to soluble derivatives of the beta amyloid precursor protein of Alzheimer's disease","volume":"171","author":"Bodmer","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jns.2017.03.031_bb0765","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/CDLI.1.1.109-110.1994","article-title":"Transforming growth factor beta in Alzheimer's disease","volume":"1","author":"Chao","year":"1993","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jns.2017.03.031_bb0770","first-page":"26","article-title":"Biological roles of fibroblast growth factor-2","volume":"18","author":"Bikfalvi","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jns.2017.03.031_bb0775","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2119\/2007-00034.Bellucci","article-title":"Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease","volume":"13","author":"Bellucci","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.jns.2017.03.031_bb0780","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1601-183X.2007.00378.x","article-title":"Neurotrophic factors in Alzheimer's disease: role of axonal transport","volume":"7","author":"Schindowski","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.jns.2017.03.031_bb0785","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neurobiolaging.2014.10.004","article-title":"Systemic administration of fibroblast growth factor-2 (FGF2) reduces BACE1 expression and amyloid pathology in APP23 mice","volume":"36","author":"Katsouri","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.03.031_bb0790","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s12072-011-9301-z","article-title":"Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis","volume":"6","author":"Tojima","year":"2011","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jns.2017.03.031_bb0795","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.atherosclerosis.2011.02.025","article-title":"Hepatocyte growth factor promotes an anti-inflammatory cytokine profile in human abdominal aortic aneurysm tissue","volume":"216","author":"Shintani","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jns.2017.03.031_bb0800","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1100\/tsw.2010.49","article-title":"Hepatocyte growth factor in synaptic plasticity and Alzheimer's disease","volume":"10","author":"Sharma","year":"2010","journal-title":"Sci. World J."},{"key":"10.1016\/j.jns.2017.03.031_bb0805","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.gt.3303094","article-title":"Alleviation of Abeta-induced cognitive impairment by ultrasound-mediated gene transfer of HGF in a mouse model","volume":"15","author":"Takeuchi","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.jns.2017.03.031_bb0810","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/dneu.20759","article-title":"Nerve growth factor as a paradigm of neurotrophins 1related to Alzheimer's disease","volume":"70","author":"Calissano","year":"2010","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.jns.2017.03.031_bb0815","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/acel.12473","article-title":"NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer's disease","volume":"15","author":"Triaca","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.jns.2017.03.031_bb0820","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1523\/JNEUROSCI.0260-15.2015","article-title":"ApoE4 and A\u03b2 oligomers reduce BDNF expression via HDAC nuclear translocation","volume":"35","author":"Sen","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2017.03.031_bb0825","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000375367","article-title":"Association between DNA methylation of the BDNF promoter region and clinical presentation in Alzheimer's disease","volume":"5","author":"Nagata","year":"2015","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"10.1016\/j.jns.2017.03.031_bb0830","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0197-4580(95)00050-O","article-title":"PDGF is associated with neuronal and glial alterations of Alzheimer's disease","volume":"16","author":"Masliah","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.03.031_bb0835","first-page":"2746","article-title":"VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor","volume":"272","author":"Sirois","year":"1997","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jns.2017.03.031_bb0840","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00005072-199906000-00006","article-title":"Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain","volume":"58","author":"Proescholdt","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2017.03.031_bb0845","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ijdevneu.2010.07.231","article-title":"Effect of VEGF and its receptor antagonist SU-5416, an inhibitor of angiogenesis, on processing of the \u03b2-amyloid precursor protein in primary neuronal cells derived from brain tissue of Tg2576 mice","volume":"28","author":"B\u00fcrger","year":"2010","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.jns.2017.03.031_bb0850","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/156720511795256026","article-title":"Correlation analysis of capillary APOE, VEGF and eNOS expression in Alzheimer brains","volume":"8","author":"Provias","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0855","first-page":"38","article-title":"Neurotrophins: from pathophysiology to treatment in Alzheimer's disease","volume":"5","author":"Schulte-Herbr\u00fcggen","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0860","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.exger.2009.10.005","article-title":"Soluble cell adhesion molecules in monocytes of Alzheimer's disease and mild cognitive impairment","volume":"45","author":"Hochstrasser","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jns.2017.03.031_bb0865","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1096\/fj.03-0364fje","article-title":"The LPS receptor (CD14) links innate immunity with Alzheimer's disease","volume":"8","author":"Fassbender","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.jns.2017.03.031_bb0870","first-page":"1309","article-title":"Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system","volume":"136","author":"Sobel","year":"1990","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jns.2017.03.031_bb0875","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jns.2004.11.001","article-title":"The role of soluble intercellular adhesion molecules in neurodegenerative disorders","volume":"228","author":"Rentzos","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2017.03.031_bb0880","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1073\/pnas.90.9.3943","article-title":"Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium","volume":"90","author":"Iademarco","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2017.03.031_bb0885","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jns.2008.05.020","article-title":"Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia","volume":"272","author":"Zuliani","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2017.03.031_bb0890","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/349796a0","article-title":"ELAM-1 is an adhesion molecule for skin-homing T cells","volume":"349","author":"Picker","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jns.2017.03.031_bb0895","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10522-011-9335-6","article-title":"Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration","volume":"12","author":"Corsi","year":"2011","journal-title":"Biogerontology"},{"key":"10.1016\/j.jns.2017.03.031_bb0900","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1468-1331.2006.01640.x","article-title":"PECAM-1, a key player in neuroinflammation","volume":"13","author":"Kalinowska","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2017.03.031_bb0905","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/IR:21:2-3:159","article-title":"Focal inflammation in the brain: role in Alzheimer's disease","volume":"21","author":"Cooper","year":"2000","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0910","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","article-title":"The complement system","volume":"343","author":"Sarma","year":"2011","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0915","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fnint.2013.00059","article-title":"Inflammatory process in Alzheimer's disease","volume":"7","author":"Meraz-R\u00edos","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.jns.2017.03.031_bb0920","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1684\/ecn.2009.0157","article-title":"Is complement good, bad, or both? New functions of the complement factors associated with inflammation mechanisms in the central nervous system","volume":"20","author":"Tahtouh","year":"2009","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.jns.2017.03.031_bb0925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157015909787602805","article-title":"Implication of complement system and its regulators in Alzheimer's disease","volume":"7","author":"Kolev","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jns.2017.03.031_bb0930","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2174\/1567205011666140812113707","article-title":"Role of complement systems in IVIG mediated attenuation of cognitive deterioration in Alzheimer's disease","volume":"11","author":"Gong","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jns.2017.03.031_bb0935","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00702-012-0797-8","article-title":"Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease","volume":"119","author":"Daborg","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jns.2017.03.031_bb0940","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.imbio.2011.07.023","article-title":"Complement activation as a biomarker for Alzheimer's disease","volume":"217","author":"Aiyaz","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.jns.2017.03.031_bb0945","doi-asserted-by":"crossref","first-page":"21812","DOI":"10.1073\/pnas.1010373107","article-title":"Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization","volume":"107","author":"Ahn","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2017.03.031_bb0950","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neuron.2010.05.014","article-title":"Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease","volume":"66","author":"Cortes-Canteli","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2017.03.031_bb0955","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13167-011-0063-4","article-title":"Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk","volume":"2","author":"Colley","year":"2011","journal-title":"EPMA J."},{"key":"10.1016\/j.jns.2017.03.031_bb0960","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.20721","article-title":"Lipoprotein-associated phospholipase A2 is associated with risk of dementia","volume":"59","author":"van Oijen","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2017.03.031_bb0965","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1567-5688(02)00045-4","article-title":"Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase","volume":"3","author":"Tselepis","year":"2002","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.jns.2017.03.031_bb0970","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.atherosclerosis.2014.04.032","article-title":"Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study","volume":"235","author":"Fitzpatrick","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jns.2017.03.031_bb0975","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4020-8831-5_9","article-title":"Altered lipid metabolism in brain injury and disorders","volume":"49","author":"Adibhatla","year":"2008","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.jns.2017.03.031_bb0980","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/jnnp.67.6.733","article-title":"Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease","volume":"67","author":"Alvarez","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2017.03.031_bb0985","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2174\/0929867321666131227161303","article-title":"Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease","volume":"21","author":"Aliev","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jns.2017.03.031_bb0990","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.4155\/fmc.13.111","article-title":"Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy","volume":"5","author":"Zhihui","year":"2013","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jns.2017.03.031_bb0995","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1172\/JCI115934","article-title":"The serpin-enzyme complex (SEC) receptor mediates the neutrophil chemotactic effect of alpha-1 antitrypsin-elastase complexes and amyloid-beta peptide","volume":"90","author":"Joslin","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jns.2017.03.031_bb1000","first-page":"213","article-title":"Elastase is associated with the neurofibrillary pathology of Alzheimer disease: a putative link between proteolytic imbalance and oxidative stress","volume":"9","author":"Smith","year":"1996","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.jns.2017.03.031_bb1005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2249.1993.tb05942.x","article-title":"High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under corticosteroid therapy","volume":"92","author":"Lecron","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jns.2017.03.031_bb1010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1600-0404.2009.01179.x","article-title":"Expression of LIF and LIF receptor beta in Alzheimer's and Parkinson's diseases","volume":"121","author":"Soilu-H\u00e4nninen","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2017.03.031_bb1015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2119\/molmed.2009.00123","article-title":"The role of macrophage migration inhibitory factor in Alzheimer's disease","volume":"16","author":"Bacher","year":"2010","journal-title":"Mol. Med."},{"key":"10.1016\/j.jns.2017.03.031_bb1020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12974-015-0396-3","article-title":"Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease","volume":"12","author":"Li","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2017.03.031_bb1025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2014.11.042","article-title":"Impacts of aging and amyloid-\u03b2 deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease","volume":"1597","author":"Bi Oh","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2017.03.031_bb1030","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1073\/pnas.0710823105","article-title":"Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade","volume":"105","author":"Jacobsen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2017.03.031_bb1035","first-page":"694","article-title":"Pentraxin 3","volume":"59","author":"Inoue","year":"2011","journal-title":"Rinsho Byori"},{"key":"10.1016\/j.jns.2017.03.031_bb1040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semarthrit.2008.03.006","article-title":"The long pentraxin 3 and its role in autoimmunity","volume":"39","author":"Ortega-Hernandez","year":"2009","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jns.2017.03.031_bb1045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glq030","article-title":"Plasma pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients","volume":"65","author":"Yano","year":"2010","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.jns.2017.03.031_bb1050","first-page":"256","article-title":"Serum amyloid P component level in Alzheimer's disease","volume":"7","author":"Nishiyama","year":"1996","journal-title":"Dementia"},{"key":"10.1016\/j.jns.2017.03.031_bb1055","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1128\/IAI.67.6.2790-2796.1999","article-title":"Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS","volume":"67","author":"de Haas","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jns.2017.03.031_bb1060","doi-asserted-by":"crossref","first-page":"26041","DOI":"10.1074\/jbc.270.44.26041","article-title":"Inhibition of Alzheimer beta-peptide fibril formation by serum amyloid P component","volume":"270","author":"Janciauskiene","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2017.03.031_bb1065","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1073\/pnas.0902640106","article-title":"Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component","volume":"106","author":"Kolstoe","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2017.03.031_bb1070","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/ard.42.6.665","article-title":"Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity","volume":"42","author":"Chambers","year":"1983","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2017.03.031_bb1075","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbalip.2006.03.013","article-title":"Serum amyloid A (SAA)-induced remodeling of CSF-HDL","volume":"1761","author":"Miida","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jns.2017.03.031_bb1080","first-page":"447","article-title":"Procalcitonin's role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator?","volume":"75","author":"Dahaba","year":"2009","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.jns.2017.03.031_bb1085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2007.07.009","article-title":"Procalcitonin is elevated in the cerebrospinal fluid of patients with dementia and acute neuroinflammation","volume":"189","author":"Ernst","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2017.03.031_bb1090","first-page":"482","article-title":"Lactoferrin in the central nervous system","volume":"39","author":"Sacharczuk","year":"2005","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.jns.2017.03.031_bb1095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/adc.67.5.657","article-title":"Biological role of lactoferrin","volume":"67","author":"S\u00e1nchez","year":"1992","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jns.2017.03.031_bb1100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neulet.2009.01.071","article-title":"Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease","volume":"452","author":"An","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2017.03.031_bb1105","first-page":"1574","article-title":"Lactotransferrin immunocytochemistry in Alzheimer and normal human brain","volume":"142","author":"Kawamata","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jns.2017.03.031_bb1110","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood.V87.6.2262.bloodjournal8762262","article-title":"The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation","volume":"87","author":"Lukacs","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jns.2017.03.031_bb1115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3233\/JAD-2008-15311","article-title":"Decreased plasma and cerebrospinal fluid levels of stem cell factor in patients with early Alzheimer's disease","volume":"15","author":"Laske","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2017.03.031_bb1120","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1017\/S1461145709990216","article-title":"Increase of SCF plasma concentration during donepezil treatment of patients with early Alzheimer's disease","volume":"12","author":"Leyhe","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jns.2017.03.031_bb1125","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3233\/JAD-2010-091486","article-title":"Endothelin-1 is elevated in Alzheimer's disease brain microvessels and is neuroprotective","volume":"21","author":"Luo","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2017.03.031_bb1130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0143-4179(92)90059-6","article-title":"Cerebrospinal fluid endothelin-1 in Alzheimer's disease and senile dementia of Alzheimer type","volume":"22","author":"Yoshizawa","year":"1992","journal-title":"Neuropeptides"},{"key":"10.1016\/j.jns.2017.03.031_bb1135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389200024605082","article-title":"Neopterin as a marker for immune system activation","volume":"3","author":"Murr","year":"2002","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jns.2017.03.031_bb1140","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1515\/CCLM.1999.070","article-title":"Increased serum neopterin concentrations in patients with Alzheimer's disease","volume":"37","author":"Leblhuber","year":"1999","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jns.2017.03.031_bb1145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00002093-200010000-00007","article-title":"Elevated plasma neopterin levels in Alzheimer disease","volume":"14","author":"Hull","year":"2000","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.jns.2017.03.031_bb1150","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jpsychires.2006.02.001","article-title":"Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin","volume":"41","author":"Blasko","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jns.2017.03.031_bb1155","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0197-4580(96)00073-5","article-title":"Binding of platelet-activating factor to platelets of Alzheimer's disease and multiinfarct dementia patients","volume":"17","author":"Hershkowitz","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.03.031_bb1160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0090-6980(02)00031-X","article-title":"Prostaglandins and other lipid mediators in Alzheimer's disease","volume":"68\u201369","author":"Bazan","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jns.2017.03.031_bb1165","first-page":"8","article-title":"Alzheimer disease: prostaglandin E2 signalling is implicated in inflammation early in the Alzheimer disease course","author":"Wood","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2017.03.031_bb1170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/jnnp.2005.063131","article-title":"Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease","volume":"77","author":"Combrinck","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2017.03.031_bb1175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s13530-014-0198-5","article-title":"Diagnostic methods and biomarkers for Alzheimer's disease","volume":"6","author":"Bagyinszky","year":"2014","journal-title":"Toxicol. Environ. Heal. Sci."},{"key":"10.1016\/j.jns.2017.03.031_bb1180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/bmm.09.89","article-title":"Biomarkers of oxidative damage and inflammation in Alzheimer's disease","volume":"4","author":"Galasko","year":"2010","journal-title":"Biomark. Med"},{"key":"10.1016\/j.jns.2017.03.031_bb1185","doi-asserted-by":"crossref","DOI":"10.1186\/alzrt29","article-title":"Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?","volume":"2","author":"Tan","year":"2010","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jns.2017.03.031_bb1190","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jns.2017.03.031_bb1195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/NDT.S75546","article-title":"Neuroinflammation in Alzheimer's disease","volume":"11","author":"Zhang","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jns.2017.03.031_bb1200","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.2217\/14622416.8.12.1735","article-title":"Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision","volume":"8","author":"Vasto","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jns.2017.03.031_bb1205","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-11-25","article-title":"Modulation of inflammation in transgenic models of Alzheimer's disease","volume":"11","author":"Birch","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2017.03.031_bb1210","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbadis.2011.10.006","article-title":"Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease","volume":"1822","author":"Mecocci","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jns.2017.03.031_bb1215","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2174\/138955708786369582","article-title":"Antioxidant therapy in Alzheimer's disease: theory and practice","volume":"8","author":"Aliev","year":"2008","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.jns.2017.03.031_bb1220","article-title":"Neuroprotective effects of curcumin on endothelin-1 mediated cell death in hippocampal neurons","author":"Stankowska","year":"2015","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.jns.2017.03.031_bb1225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-016-0054-4","article-title":"The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-\u03b1, TGF-\u03b2 and IFN-\u03b3","volume":"5","author":"Zheng","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jns.2017.03.031_bb1230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neubiorev.2014.12.006","article-title":"Diverse functional roles of lipocalin-2 in the central nervous system","volume":"49","author":"Jha","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jns.2017.03.031_bb1235","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pneurobio.2016.08.001","article-title":"Lipocalin-2 as a therapeutic target for brain injury: an astrocentric perspective","volume":"144","author":"Suk","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jns.2017.03.031_bb1240","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jns.2011.03.023","article-title":"Increased plasma levels of lipocalin 2 in mild cognitive impairment","volume":"305","author":"Choi","year":"2011","journal-title":"J. Neurol. Sci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17302009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17302009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T15:38:05Z","timestamp":1750174685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X17302009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":248,"alternative-id":["S0022510X17302009"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.03.031","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}